Literature DB >> 29878087

Time to hospital arrival among patients with acute myocardial infarction in China: a report from China PEACE prospective study.

Wenchi Guan1, Arjun K Venkatesh2,3, Xueke Bai1, Si Xuan4, Jing Li1, Xi Li1, Haibo Zhang1, Xin Zheng1, Frederick A Masoudi5, John A Spertus6, Harlan M Krumholz2,7,8, Lixin Jiang1.   

Abstract

Aims: Few contemporary studies have reported the time between acute myocardial infarction (AMI) symptoms onset and hospital arrival, associated factors, and patient perceptions of AMI symptoms and care seeking. We sought to study these issues using data from China, where AMI hospitalizations are increasing. Methods and results: We used data from the China PEACE prospective AMI study of 53 hospitals across 21 provinces in China. Patients were interviewed during index hospitalization for information of symptom onset, and perceived barriers to accessing care. Regression analyses were conducted to explore factors associated with the time between symptom onset and hospital arrival. The final sample included 3434 patients (mean age 61 years). The median time from symptom onset to hospital arrival was 4 h (interquartile range 2-7.5 h). While 94% of patients reported chest pain or chest discomfort, only 43% perceived symptoms as heart-related. In multivariable analyses, time to hospital arrival was longer by 14% and 39% for patients failing to recognize symptoms as cardiac and those with rural medical insurance, respectively (both P < 0.001). Compared with patients with household income over 100 000 RMB, those with income of 10 000-50 000 RMB, and <10 000 RMB had 16% and 23% longer times, respectively (both P = 0.03).
Conclusion: We reported an average time to hospital arrival of 4 h for AMI in China, with longer time associated with rural medical insurance, failing to recognize symptoms as cardiac, and low household income. Strategies to improve the timeliness of presentation may be essential to improving outcomes for AMI in China. Clinical trial registration: https://clinicaltrials.gov/ct2/show/NCT01624909.

Entities:  

Mesh:

Year:  2019        PMID: 29878087      PMCID: PMC6307335          DOI: 10.1093/ehjqcco/qcy022

Source DB:  PubMed          Journal:  Eur Heart J Qual Care Clin Outcomes        ISSN: 2058-1742


Introduction

The benefits of reperfusion therapy for patients with acute myocardial infarction (AMI) depend on timely patient presentation for acute care., Prolonged time intervals have been associated with worse outcomes, and are an international problem. In the United States and other Western countries, the median time from symptoms onset to hospital arrival is 2–3 h [2 h for ST-elevated myocardial infarction (STEMI), 3 h for non ST-elevated myocardial infarction (NSTEMI)],, yet approximately 10% of patients still arrive at the hospital greater than 12 h after noticing symptoms., In countries with limited access to advanced health care, less developed emergency response systems, and limited personal and public financial resources for health care, time intervals to hospital arrival are reportedly worse. Few contemporary studies of delays to hospital arrival incorporate patients’ perspectives and perceptions regarding seeking care. Moreover, we know little about whether patient characteristics such as education, medical insurance, income, or psychosocial status are associated with delays. Understanding both the extent of time to hospital arrival and the factors contributing to prolonged time intervals may help identify barriers to timely presentation, and help guide future improvement strategies and interventions. This issue is particularly important in China where rates of AMI are increasing rapidly; by 2030 the country is estimated to have over 23 million AMIs each year, nearly three times as many as those in 2010. The China Patient-Centered Evaluative Assessment of Cardiac Events Prospective Study of Acute Myocardial Infarction (China PEACE-Prospective AMI Study) was specifically designed to study, among other topics, the time to hospital arrival and factors associated with it, as a means of developing future improvement programs. The study captured details of symptom onset and factors known to be related to health care access for AMI, to examine care seeking delays and associated factors. Specifically, we aim to describe the time from symptom onset to hospital arrival, patient perceptions regarding AMI symptoms and care-seeking, and factors associated with longer time to hospital arrival.

Methods

Study design of China PEACE-prospective AMI study

The design of the China PEACE-Prospective AMI Study has been published previously. In brief, the study consecutively registered patients aged 18 or older and were hospitalized for AMI within 24 h of symptom onset from 53 acute-care hospitals (35 tertiary and 18 secondary hospitals) in 21 Chinese provinces. Eligible patients who provided informed consent were enrolled and interviewed during index hospitalization, and followed up at 1, 6, and 12 months following hospital discharge. The first patient was enrolled in December 2012 and the last patient was enrolled in May 2014. Data were collected via centralized medical chart abstraction, while interviews and physical examinations were conducted locally by site investigators. Medical chart abstraction quality was monitored by randomly auditing 5% of the medical charts. The chart abstraction achieved an overall accuracy of over 98%. Interviews were completed using tablet computers that employed data entry validation to ensure the accuracy and completeness of data. The central ethics committee at the NCCD and local internal ethics committees at sites and the Yale University Institutional Review Board approved the China PEACE-Prospective AMI Study. All patients provided written informed consent. The study is registered at www.clinicaltrials.gov (NCT01624909). The funder of the study had no role in the study design, data collection, data analyses, data interpretation, or writing of the report.

Study sample

We limited the study sample to patients with available data of time intervals from symptoms onset to hospital arrival. Patients who were transferred from another hospital were excluded because arrival at study hospitals did not reflect the patient’s first contact with acute care.

Study outcomes

The primary outcome was time to hospital arrival, which was defined as the time between symptom onset and hospital arrival in hours. This interval was calculated from the documented timestamp of symptom onset and the documented timestamp of hospital arrival; if timestamps were not available, we used the patient-reported duration from symptom onset to hospital arrival. The timestamps and the patient-reported duration were collected from the patient interview questionnaire.

Patient characteristics

Through the interview, we collected detailed information about symptom onset, patients’ perception of symptoms, reasons for patient-reported delays in seeking care; we also collected various demographic, clinical, and psychosocial factors hypothesized to be associated with prolonged time to hospital arrival from medical chart abstraction. We designed a multiple-choice question for AMI symptoms that asked patients to report all acute symptoms including chest pain and chest discomfort, sweating, weakness or fatigue, nausea, shortness of breath, radiating pain, palpitation, dizziness, indigestion or stomach pain/discomfort, confusion, and other symptoms. A distinct question was asked about patient perceptions regarding symptoms, i.e. whether the symptoms were perceived to be heart-related. Patients also reported individual reasons for ‘waiting before seeking care’, which included lack of time, perception of non-severe symptoms, perception of intermittent symptoms, lack of assistance for a hospital visit, concerns for cost, embarrassment or fear, or none of the above. We also collected data about time of symptom onset—weekdays were defined as Monday through Friday and weekends as Saturday and Sunday. In addition to symptomology, we also collected socio-demographic data (age, gender, marriage status, employment status, level of education, health insurance status, household income), comorbidities and cardiovascular disease risk factors (based on medical history and admission diagnosis), medical history, and AMI type. Each patient was also interviewed during the index hospitalization to assess several patient-reported measures of health status, including generic health-related quality of life measured by the EuroQol five dimensions questionnaire (EQ5D) scale,, disease-specific quality of life evaluated by the Seattle Angina Questionnaire Angina Frequency (SAQ-AF), depression by the Patient Health Questionnaire Depression (PHQ-8), social support by the ENRICHD Social Support Instrument (ESSI), and stress by the Perceived Stress Scale (PSS). As this study was conducted contemporaneously with acute care, patients responded to interview questions after the initial period of treatment, so that it would not interfere with acute therapy.

Statistical analyses

Categorical variables were expressed as frequencies and percentages and analysed using χ2 tests; continuous variables were described as medians and interquartile ranges (IQRs) and analysed by the Kruskal–Wallis test. To characterize the patient characteristics for different time groups, we first examined the distribution of the primary outcome and then classified patients into one of three mutually exclusive categories: (i) less than or equal to 2 h; (ii) 2–6 h; and (iii) greater than 6 h. We chose 2 h and 6 h as cut-offs because these time points were commonly used in previous studies, as well as in clinical practice; we also defined time to hospital arrival >6 h as ‘extreme delay’. We, subsequently, fit a mixed model to estimate the associations between time to hospital arrival and patient characteristics. Because the distribution of time to hospital arrival was skewed, we applied a log-transformation to normalize its distribution prior to regression analysis. The estimated coefficients represent the percentage change for the time to hospital arrival for each 1-unit change in an independent variable., Candidate variables included age, sex, marriage status, work status, education level, household income, medical insurance, diabetes mellitus (DM), hypertension, hypercholesterolaemia, current smoking, medical history (AMI, percutaneous coronary intervention, coronary artery bypass grafting, angina, heart failure, and stroke), time of symptoms onset, onset symptoms, perceiving symptoms as cardiac, EQ5D index score, EuroQol five dimensions questionnaire visual analog scale (EQ5D-VAS), depression, stress level, social support, and SAQ-AF score. Missing data occurred only for time of symptoms onset (7.5%) and was reported as a separate group in the model. The model was fitted with hospital-specific random intercepts to account for within-hospital and between-hospital variations. We also did secondary analysis to identify factors associated with extreme delay using logistic regression; candidate variables included in the logistic model were the same as those in the mixed model. All comparisons were two-tailed, with a P < 0.05 considered statistically significant. All statistical analyses were performed using SAS software (version 9.4, SAS Institute, Cary, NC, USA).

Results

Study cohort

The final study sample included 3434 patients (81.5% of the total AMI cohort; Figure ; baseline characteristics of patients included and excluded in this study were shown in Appendix, Table A1), 43% had documented timestamps of both symptom onset and hospital arrival, and 57% reported duration from symptom onset to hospital arrival. Among them, 799 (23%) of patients were female, 2808 (81.8%) were STEMI, and the mean age was 61 years (SD 12 years). Across the cohort, 1435 (42%) were currently employed; 1137(33%) had an education level equal to or greater than high school; 1944 (57%) had household income lower than 50 000 RMB (∼7142 USD) per year. Together, medical insurance for urban workers and residents and rural medical insurance accounted for the two major insurance types (56% and 36%, respectively). Cardiovascular risk factors were common: hypertension (56%), DM (23%), current smoking (58%) and hypercholesterolaemia (30%). Two-thirds of the patients had symptom onset during weekdays (Table ).
Figure 1

A flowchart of identifying the study sample.

Table A1

Baseline characteristics of patients included and excluded in the article

VariablesTotalEnrolledNot enrolled P-value
Socio-demographics
 Age60.9 (11.8)60.7 (11.9)61.6 (11.6)0.108
 Female995 (23.6)799 (23.3)196 (25.2)0.254
 Married3674 (87.2)3007 (87.6)667 (85.7)0.167
 Working full or part time1727 (41.0)1435 (41.8)292 (37.5)0.029
 Education level ≥ high school1403 (33.3)1137 (33.1)266 (34.2)0.564
Health insurance
 Rural medical insurance1648 (39.1)1339 (39.0)309 (39.7)0.708
Household income
 <10 000 RMB537 (12.7)430 (12.5)107 (13.8)0.284
 10 000–50 000 RMB1824 (43.3)1514 (44.1)310 (39.8)
 50 000–10 000 RMB622 (14.8)501 (14.6)121 (15.6)
 >100 000 RMB258 (6.1)215 (6.3)43 (5.5)
 Patient unclear or refuse to answer649 (15.4)498 (14.5)151 (19.4)
CVD risk factors
 Diabetes mellitus999 (23.7)798 (23.2)201 (25.8)0.124
 Hypertension1840 (43.7)1477 (43.0)363 (46.7)0.064
 Hypercholesterolaemia1114 (26.4)880 (25.6)234 (30.1)0.011
 Current smoking2 (0.0)1 (0.0)1 (0.1)0.25
 Abnormal waist circumference2130 (50.6)1760 (51.3)370 (47.6)0.063
Medical history
 Prior heart failure323 (7.7)232 (6.8)91 (11.7)<0.001
 Prior stroke675 (16.0)571 (16.6)104 (13.4)0.025
 Prior angina167 (4.0)136 (4.0)31 (4.0)0.975
 Prior AMI328 (7.8)275 (8.0)53 (6.8)0.261
 Prior PCI273 (6.5)238 (6.9)35 (4.5)0.013
 Prior CABG5 (0.1)5 (0.1)0 (0.0)0.287
Time of symptoms onset
 Weekday2811 (66.7)2287 (66.6)524 (67.4)0.843
 Weekend1089 (25.9)889 (25.9)200 (25.7)
 Unclear312 (7.4)258 (7.5)54 (6.9)
Onset symptoms
 Chest pain or discomfort3927 (93.2)3233 (94.1)694 (89.2)<0.001
 Other ischaemic symptoms3503 (83.2)2874 (83.7)629 (80.8)0.056
Symptoms perceived as heart-related problems1818 (43.2)1491 (43.4)327 (42.0)0.48
Psychosocial factors
 Health-related quality of life (EQ5D index score, mean)0.9 (0.2)0.9 (0.2)0.8 (0.2)0.051
 Health-related quality of life (EQ5D-VAS, mean)76.1 (16.9)76.1 (16.6)76.1 (18.2)0.587
 Depression (PHQ-8)256 (6.1)212 (6.2)44 (5.7)0.585
 Low social support (ESSI)671 (15.9)525 (15.3)146 (18.8)0.009
 Stress (PSS-4)3192 (75.8)2667 (77.7)525 (67.5)<0.001
 SAQ Angina Frequency86.5 (21.3)87.2 (20.5)83.4 (24.0)<0.001

PSS, Perceived Stress Scale: CVD, cardiovascular disease; AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; EQ5D, EuroQol five dimensions questionnaire; EQ5D-VAS, EuroQol five dimensions questionnaire visual analog scale; PHQ-8, Patient Health Questionnaire depression scale; ESSI, ENRICHD Social Support Instrument; SAQ, Seattle Angina Questionnaire.

Baseline characteristics of study cohort CVD, cardiovascular disease; AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; EQ5D, EuroQol five dimensions questionnaire; EQ5D-VAS, EuroQol five dimensions questionnaire visual analog scale; PHQ-8, Patient Health Questionnaire depression scale; ESSI, ENRICHD Social Support Instrument; PSS, Perceived Stress Scale; SAQ, Seattle Angina Questionnaire. A flowchart of identifying the study sample.

Time from symptom onset to hospital arrival

The median time to hospital arrival was 4 h (IQR 2–7.5 h). The distribution of time to hospital arrival is shown in Figure . There were 29% of patients had time from symptom onset to hospital arrival greater than 6 h.
Figure 2

Distribution of time from symptom onset to hospital arrival.

Distribution of time from symptom onset to hospital arrival.

Patient-reported symptoms and reasons for delay in seeking care

Almost all patients (94%) reported typical symptoms of chest pain or chest discomfort (Table ), and 84% also reported other ischaemic symptoms in addition to chest pain/discomfort. However, less than half of patients (43%) perceived the symptoms as heart-related problems. Among all patients, 50% of the cohort reported delays in seeking medical care and a large proportion of prolonged time to acute care could be attributed to ‘symptoms did not seem bad enough for emergency care’ (27%), and ‘symptoms would come and go over time’ (24%); these factors were also more pronounced among patients with extreme delay (i.e. greater than 6 h) (Table ). Patient-reported onset symptoms (multiple choice) Patient-reported reasons for delays in seeking medical care (among those reported to delay before seeking care)

Patient factors associated with prolonged times in care seeking

Several patient-reported perceptions and patient factors were associated with longer time to hospital arrival in unadjusted analyses, as shown in Table . Results from the log-transformed mixed model are given in Figure A. Patients who had rural medical insurance had 39% longer times than those with other types of medical insurance (mainly urban medical insurance) (P < 0.001). Compared with patients with household income over 100 thousand RMB, those in the 10–50 thousand RMB group and less than 10 thousand RMB group had 16% and 23% longer adjusted times, respectively (both P = 0.03). Time to hospital arrival was longer by 14% for patients that failed to recognize symptoms as cardiac (P < 0.001). Conversely, patients with a stroke history had 8% shorter times than those without prior stroke (P = 0.048).
Figure 3

(A) Factors associated with time from symptom onset to hospital arrival in log-transformed mixed model. Variables associated with longer or shorter time to hospital arrival among patients with acute myocardial infarction are shown along the vertical axis. The percentage of 0 shows no difference in time from symptoms onset to hospital arrival for different subgroups. Each dot represents the point estimate of the effect of that variable in the model; the line shows the 95% confidence interval. (B) Factors associated with extreme delay in hospital arrival (greater than 6 h) in multivariable logistic model. Variables associated with extreme delay in hospital arrival (greater than 6 h) among patients with acute myocardial infarction are shown along the vertical axis. The adjusted odds ratio of 1 shows no difference in time from symptoms onset to hospital arrival for different subgroups. Each dot represents the point estimate of the effect of that variable in the model; the line shows the 95% confidence interval. CI, confidence interval; CVD, cardiovascular disease; PCI, percutaneous coronary intervention.

(A) Factors associated with time from symptom onset to hospital arrival in log-transformed mixed model. Variables associated with longer or shorter time to hospital arrival among patients with acute myocardial infarction are shown along the vertical axis. The percentage of 0 shows no difference in time from symptoms onset to hospital arrival for different subgroups. Each dot represents the point estimate of the effect of that variable in the model; the line shows the 95% confidence interval. (B) Factors associated with extreme delay in hospital arrival (greater than 6 h) in multivariable logistic model. Variables associated with extreme delay in hospital arrival (greater than 6 h) among patients with acute myocardial infarction are shown along the vertical axis. The adjusted odds ratio of 1 shows no difference in time from symptoms onset to hospital arrival for different subgroups. Each dot represents the point estimate of the effect of that variable in the model; the line shows the 95% confidence interval. CI, confidence interval; CVD, cardiovascular disease; PCI, percutaneous coronary intervention. Similarly, in the secondary analyses assessing factors associated with extreme delay, patients who had rural medical insurance, and those who failed to recognize symptoms as cardiac were more likely to have time to hospital arrival >6 h [odds ratio (OR) 1.7, 95% confidence interval (CI) 1.4–2.1; OR 1.5, 95% CI 1.2–1.8, respectively; both P < 0.001] (Figure B).

Discussion

In this large prospectively enrolled sample of patients with AMI, we found that both patient socio-demographic factors such as rural medical insurance and lower household income, and patient-reported factors, such as failing to recognize symptoms as cardiac, were associated with longer time to hospital arrival. These findings reveal important vulnerabilities in accessing timely acute cardiovascular care. However, the magnitude of effect from each factor was overshadowed by the overall duration of delay in China. Furthermore, we identified significant problem of unawareness of AMI-related symptoms, which were associated with longer times. Our study identifies important opportunities for future improvement initiatives and policy efforts to improve timely care seeking, particularly for time-sensitive conditions such as AMI. Time to hospital arrival in China is longer than what has been reported in both China and Western countries. We describe a median time of 4 h in China; by contrast, the international Global Registry of Acute Coronary Events (GRACE) study reported that in 2006, the median care seeking time ranged between 1.7–2.3 h for STEMI and 1.9–2.7 h for NSTEMI in Western countries. The prolonged time to hospital arrival attenuates the benefit of reperfusion therapy for patients with STEMI, which is particularly important as STEMI accounts for about 80% of patients with AMI in China. The time to hospital arrival is also longer than those previously reported in China.,, However, prior studies were usually retrospective, conducted in cities, and were limited to single hospital/region with small sample size (less than 1000 patients). In contrast, our work is the largest and first multi-centre study that includes hospitals in both urban and rural areas, incorporates patients’ perspectives from prospective interviews, and therefore, provides a comprehensive assessment of care seeking times for AMI in China. It is no doubt that there are substantial variations in distances to hospital in a huge country like China, which may affect the time to hospital arrival. However, AMI is an acute condition that requires seeking medical help in the nearest hospital. In China, even in rural areas, patients with AMI could arrive at the nearest county hospital for treatment within a relatively short time period. We found several patient-level factors that were associated with delayed presentations, such as rural medical insurance. Rural insurance covers 97% of rural residents (rural or urban residents were determined by the Hukou policy in China), however, this finding is not easily explained by distance to care. Patients with rural medical insurance live in both rural and urban areas due to China’s urbanization, and patients with rural medical insurance in both geographies had longer time to hospital arrival. Out-of-pocket financial concerns may partially explain the result, as household incomes as well as reimbursement rates vary for patients with different types of medical insurance; it is also possible that patients with rural medical insurance had poorer health literacy of AMI than those from urban areas. Lower income is also associated with delayed presentation times independent of insurance type, which indicated that economic status could help to identify vulnerable groups for more educational support. Contrary to our expectations, we did not find associations between psychosocial factors and prolonged time to arrival; it is possible that psychosocial factors play a more important role in long-term prognosis, rather than acute care-seeking behaviours. Factors associated with prolonged time to hospital arrival in our study are different from those reported in Western studies. Factors such as older age, DM, female, prior angina, prior AMI, have been commonly reported to be related to delayed presentation in previous Western studies; ,, however, these factors were not associated with delays to hospital arrival in our work. Meanwhile, few previous studies have examined the effect of social and psychosocial factors. It is possible that in China, social factors such as medical insurance and income play a more important role, overshadowing the impact of demographic and clinical factors. Future study is needed to examine our hypothesis and understand the underlying mechanism. A particularly important insight from this work is the association of patient-reported symptoms and reasons for delaying in seeking care reveal substantial barriers in AMI awareness. Over half of the patients with AMI did not perceive their symptoms as heart-related, although almost all reported typical symptoms of chest pain; nearly half of the patients reporting delays in seeking medical care services also reported lack of awareness of the symptoms’ severity. Such findings reveal that many patients may lack the knowledge of AMI symptoms and risks of AMI, which remains a major concern because awareness of AMI symptoms is a prerequisite to shorten time to hospital arrival. To our knowledge, little is known about efforts to narrow patient education gaps in China. Public education campaigns in Western countries designed to reduce time to hospital arrival for patients with AMI have shown mixed results. The largest study to date, the Rapid Early Action for Coronary Treatment (REACT) trial, failed to shorten time to hospital arrival in the USA. However, authors of the REACT study noted that this campaign would be more likely to succeed in a context where there are relatively long time to hospital arrival at baseline, a less competitive media environment, and a centrally organized health care system. Due to its central coordinating and planning system, China may have a greater capacity to implement strategies and policies more rapidly and consistently. Moreover, STEMI, which usually presents with more typical symptoms than NSTEMI, is preponderant in China; therefore, it is possible that awareness regarding unrelenting chest pain as a prompt to recognize AMI in the circumstances of education campaign may carry more impact in China. Our findings suggest several principles for future improvement efforts for patients with AMI in China and perhaps other countries. First, substantial opportunity exists to reduce time to hospital arrival in China, particularly through interventions aimed at improving patient awareness of symptoms and responsiveness to seek care. Given that the overall duration of time to hospital arrival in China is worrying, such interventions should target all patients at risk for AMI, not just those who have individual risk factors for longer delays. Second, a mix of socio-demographic and patient-reported factors should be acknowledged as contributing to longer time to hospital arrival; there should be intensive strategies tailored to these vulnerable groups. Third, novel, multi-dimensional strategies should be developed and tested in order to address the knowledge gaps. The current dramatic growth of electronic media and mobile health applications offer powerful platforms for effective education at a lower cost. By making clear strategies as well as testing these new tools, China may implement effective improvement initiatives to shorten delays to hospital and provide solutions for other countries facing similar challenges of acute care access.

Limitations

Certain limitations should be considered when interpreting our results. First, although a strength of our design is the prospective interview of patients, those enrolled patients may have been subject to recall bias regarding symptom onset time. However, documenting time to hospital arrival by patients’ recall has been widely used in other studies, and there is no better way to collect this information. Second, our findings are limited to those who successfully survived through pre-hospital period to hospital arrival, suggesting that the clinical ramifications of our findings may be interpreted as conservative. Third, we are unable to assess time for transportation, and the use of ambulance services; therefore, investigations on transportation delays are warranted in future studies.

Conclusion

We reported a median time of 4 h for time to access care for AMI in China, which was worse than previously reported, especially among patients with rural insurance, low household income, and those failing to recognize symptoms as cardiac. Notably, the poor awareness of AMI symptoms and severity contributed to delays in seeking hospital care for AMI. Future initiatives are needed to improve the responsiveness to seek AMI care.
Table 1

Baseline characteristics of study cohort

CharacteristicsNumber of patients (%)≤2 h, n (%)2–6 h, n (%)>6 h, n (%)P-value
Socio-demographics
 Age60.7 (11.9)60.5 (12.0)60.7 (11.8)61.0 (11.9)0.539
 Female799 (23.3)256 (22.3)282 (21.8)261 (26.2)0.031
 Married3007 (87.6)1020 (88.9)1137 (88.1)850 (85.4)0.045
 Working full or part time1435 (41.8)478 (41.6)541 (41.9)416 (41.8)0.991
 Education level ≥ high school1137 (33.1)450 (39.2)400 (31.0)287 (28.8)<0.001
Health insurance<0.001
 Rural medical insurance1225 (35.7)327 (28.5)470 (36.4)428 (43.0)
Household income<0.001
 <10 000 RMB430 (12.5)123 (10.7)145 (11.2)162 (16.3)
 10 000–50 000 RMB1514 (44.1)500 (43.6)586 (45.4)428 (43.0)
 50 000–10 000 RMB501 (14.6)203 (17.7)183 (14.2)115 (11.6)
 >100 000 RMB215 (6.3)97 (8.4)65 (5.0)53 (5.3)
 Patient unclear or refuse to answer774 (22.5)225 (19.6)312 (24.2)237 (23.8)
CVD risk factors
 Diabetes mellitus798 (23.2)266 (23.2)293 (22.7)239 (24.0)0.757
 Hypertension1909 (55.6)652 (56.8)706 (54.7)551 (55.4)0.571
 Hypercholesterolaemia1017 (29.6)386 (33.6)374 (29.0)257 (25.8)<0.001
 Current smoking2001 (58.3)680 (59.2)781 (60.5)540 (54.3)0.008
 Abnormal waist circumference1760 (51.3)603 (52.5)668 (51.7)489 (49.1)0.268
Medical history
 Prior heart failure232 (6.8)86 (7.5)79 (6.1)67 (6.7)0.403
 Prior stroke567 (16.5)197 (17.2)233 (18.0)137 (13.8)0.018
 Prior angina136 (4.0)41 (3.6)49 (3.8)46 (4.6)0.428
 Prior AMI275 (8.0)105 (9.1)115 (8.9)55 (5.5)0.003
 Prior PCI238 (6.9)84 (7.3)109 (8.4)45 (4.5)0.001
 Prior CABG5 (0.1)2 (0.2)2 (0.2)1 (0.1)0.900
Time of symptoms onset0.034
 Weekday2287 (66.6)740 (64.5)864 (66.9)683 (68.6)
 Weekend889 (25.9)301 (26.2)334 (25.9)254 (25.5)
 Unclear258 (7.5)107 (9.3)93 (7.2)58 (5.8)
Onset symptoms
 Chest pain or discomfort3233 (94.1)1070 (93.2)1233 (95.5)930 (93.5)0.030
 Other ischaemic symptoms2874 (83.7)952 (82.9)1093 (84.7)829 (83.3)0.475
Symptoms perceived as heart-related problems1491 (43.4)533 (46.4)593 (45.9)365 (36.7)<0.001
Psychosocial factors
 Health-related quality of life (EQ5D index score, mean)0.9 (0.2)0.9 (0.2)0.9 (0.2)0.9 (0.2)0.210
 Health-related quality of life (EQ5D-VAS, mean)76.1 (16.6)75.8 (17.4)76.8 (16.1)75.6 (16.3)0.269
 Depression (PHQ-8)212 (6.2)75 (6.5)70 (5.4)67 (6.7)0.358
 Low social support (ESSI)760 (22.1)271 (23.6)275 (21.3)214 (21.5)0.335
 Stress (PSS-4)2667 (77.7)904 (78.7)1010 (78.2)753 (75.7)0.194
 SAQ Angina Frequency87.2 (20.5)87.5 (20.9)88.1 (19.7)85.8 (21.2)0.009

CVD, cardiovascular disease; AMI, acute myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; EQ5D, EuroQol five dimensions questionnaire; EQ5D-VAS, EuroQol five dimensions questionnaire visual analog scale; PHQ-8, Patient Health Questionnaire depression scale; ESSI, ENRICHD Social Support Instrument; PSS, Perceived Stress Scale; SAQ, Seattle Angina Questionnaire.

Table 2

Patient-reported onset symptoms (multiple choice)

SymptomsNumber of patients (%)
Chest pain or discomfort3233 (94.2)
Sweating2308 (67.2)
Weakness of fatigue1064 (31.0)
Nausea1053 (30.7)
Shortness of breath1000 (29.1)
Radiating pain in neck, shoulder, or arms957 (27.9)
Palpitation764 (22.3)
Dizziness562 (16.4)
Indigestion or stomach pain/discomfort439 (12.8)
Confusion151 (4.4)
No acute symptoms6 (0.2)
Unknown5 (0.2)
Table 3

Patient-reported reasons for delays in seeking medical care (among those reported to delay before seeking care)

Self-reported delayed reasons for seeking medical careNumber of patients (%)≤2 h, n (%)2–6 h, n (%)>6 h, n (%)P-value
Didn’t have time to go to the doctor78 (2.3)18 (1.6)24 (1.9)36 (3.6)0.266
Symptoms did not seem bad enough for emergency care912 (26.6)244 (21.2)310 (24.0)358 (36.0)0.182
Symptoms would come and go over time (not persistent)836 (24.3)244 (21.2)297 (23.0)295 (30.0)0.065
Transportation-waited for someone to drive me to hospital181 (5.3)32 (2.8)67 (5.2)82 (8.2)0.008
A concerns about the cost49 (1.4)8 (0.7)21 (1.6)20 (2.0)0.229
Embarrassment or fear8 (0.2)4 (0.4)3 (0.2)1 (0.1)0.229
None of above40 (1.1)15 (1.3)16 (1.2)9 (0.9)0.111
Other reasons162 (4.6)46 (4.0)50 (3.9)66 (6.6)0.392
  31 in total

1.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

2.  A short social support measure for patients recovering from myocardial infarction: the ENRICHD Social Support Inventory.

Authors:  Pamela H Mitchell; Lynda Powell; James Blumenthal; Jennifer Norten; Gail Ironson; Carol Rogers Pitula; Erika Sivarajan Froelicher; Susan Czajkowski; Marston Youngblood; Marc Huber; Lisa F Berkman
Journal:  J Cardiopulm Rehabil       Date:  2003 Nov-Dec       Impact factor: 2.081

Review 3.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

4.  Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial.

Authors:  R V Luepker; J M Raczynski; S Osganian; R J Goldberg; J R Finnegan; J R Hedges; D C Goff; M S Eisenberg; J G Zapka; H A Feldman; D R Labarthe; P G McGovern; C E Cornell; M A Proschan; D G Simons-Morton
Journal:  JAMA       Date:  2000-07-05       Impact factor: 56.272

5.  Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial.

Authors:  P B Berger; S G Ellis; D R Holmes; C B Granger; D A Criger; A Betriu; E J Topol; R M Califf
Journal:  Circulation       Date:  1999-07-06       Impact factor: 29.690

6.  Time to treatment and the impact of a physician on prehospital management of acute ST elevation myocardial infarction: insights from the ASSENT-3 PLUS trial.

Authors:  R C Welsh; W Chang; P Goldstein; J Adgey; C B Granger; F W A Verheugt; L Wallentin; F Van de Werf; P W Armstrong
Journal:  Heart       Date:  2005-03-17       Impact factor: 5.994

7.  Follow-up of a 1-year media campaign on delay times and ambulance use in suspected acute myocardial infarction.

Authors:  J Herlitz; M Blohm; M Hartford; B W Karlson; R Luepker; S Holmberg; M Risenfors; B Wennerblom
Journal:  Eur Heart J       Date:  1992-02       Impact factor: 29.983

8.  Trends in prehospital delay time and use of emergency medical services for acute myocardial infarction: experience in 4 US communities from 1987-2000.

Authors:  Aileen P McGinn; Wayne D Rosamond; David C Goff; Herman A Taylor; J Shawn Miles; Lloyd Chambless
Journal:  Am Heart J       Date:  2005-09       Impact factor: 4.749

9.  Depressive symptoms and health-related quality of life: the Heart and Soul Study.

Authors:  Bernice Ruo; John S Rumsfeld; Mark A Hlatky; Haiying Liu; Warren S Browner; Mary A Whooley
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

10.  International comparison of factors associated with delay in presentation for AMI treatment.

Authors:  Sharon McKinley; Kathleen Dracup; Debra K Moser; Carol Ball; Keiko Yamasaki; Cho Ja Kim; Maree Barnett
Journal:  Eur J Cardiovasc Nurs       Date:  2004-09       Impact factor: 3.908

View more
  9 in total

1.  Pre-hospital delay in patients with acute myocardial infarction in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project.

Authors:  Dan-Qing Hu; Yong-Chen Hao; Jun Liu; Na Yang; Yi-Qian Yang; Zhao-Qing Sun; Dong Zhao; Jing Liu
Journal:  J Geriatr Cardiol       Date:  2022-04-28       Impact factor: 3.189

2.  Knowledge of Heart Disease, Preventive Behavior and Source of Information in a Multi-ethnic Asian Population: A Population-Based Survey.

Authors:  Zijuan Huang; Qai Ven Yap; Yiong Huak Chan; Jien Sze Ho; Swee Yaw Tan; Woon Puay Koh; Terrance Chua; Sungwon Yoon
Journal:  J Community Health       Date:  2021-02

3.  The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats.

Authors:  Lei Gong; Xuyang Wang; Jinyu Pan; Mingjun Zhang; Dian Liu; Ming Liu; Li Li; Fengshuang An
Journal:  Open Med (Wars)       Date:  2020-12-11

Review 4.  Mouse models of myocardial infarction: comparing permanent ligation and ischaemia-reperfusion.

Authors:  Carla De Villiers; Paul R Riley
Journal:  Dis Model Mech       Date:  2020-11-18       Impact factor: 5.758

Review 5.  Prognostic implications for patients after myocardial infarction: an integrative literature review and in-depth interviews with patients and experts.

Authors:  Seon Young Hwang; Sun Hwa Kim; In Ae Uhm; Jeong-Hun Shin; Young-Hyo Lim
Journal:  BMC Cardiovasc Disord       Date:  2022-08-02       Impact factor: 2.174

Review 6.  Cytokine storm: behind the scenes of the collateral circulation after acute myocardial infarction.

Authors:  Weixin He; Peixian Chen; Qingquan Chen; Zongtong Cai; Peidong Zhang
Journal:  Inflamm Res       Date:  2022-07-25       Impact factor: 6.986

7.  Rationale and design of the Henan ST elevation myocardial infarction (STEMI) registry: a regional STEMI project in predominantly rural central China.

Authors:  You Zhang; Shan Wang; Shuyan Yang; Shanshan Yin; Qianqian Cheng; Muwei Li; Datun Qi; Xianpei Wang; Zhongyu Zhu; Luosha Zhao; Dayi Hu; Chuanyu Gao
Journal:  BMC Cardiovasc Disord       Date:  2019-11-28       Impact factor: 2.298

8.  Cardiac symptom attribution and knowledge of the symptoms of acute myocardial infarction: a systematic review.

Authors:  Benedikt Birnbach; Jens Höpner; Rafael Mikolajczyk
Journal:  BMC Cardiovasc Disord       Date:  2020-10-14       Impact factor: 2.298

9.  Pre-hospital delay among patients with acute myocardial infarction in Saudi Arabia. A cross-sectional study.

Authors:  Ahmed F ALAhmadi; Mohammed F ALSaedi; Abdullah E Alahmadi; Mohammad G Alharbi; Ibraheem H Alharbi; Sami A Radman Al-Dubai
Journal:  Saudi Med J       Date:  2020-08       Impact factor: 1.484

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.